Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun 19:5:71.
doi: 10.3389/fcvm.2018.00071. eCollection 2018.

Actionable Metabolic Pathways in Heart Failure and Cancer-Lessons From Cancer Cell Metabolism

Affiliations
Review

Actionable Metabolic Pathways in Heart Failure and Cancer-Lessons From Cancer Cell Metabolism

Anja Karlstaedt et al. Front Cardiovasc Med. .

Abstract

Recent advances in cancer cell metabolism provide unprecedented opportunities for a new understanding of heart metabolism and may offer new approaches for the treatment of heart failure. Key questions driving the cancer field to understand how tumor cells reprogram metabolism and to benefit tumorigenesis are also applicable to the heart. Recent experimental and conceptual advances in cancer cell metabolism provide the cardiovascular field with the unique opportunity to target metabolism. This review compares cancer cell metabolism and cardiac metabolism with an emphasis on strategies of cellular adaptation, and how to exploit metabolic changes for therapeutic benefit.

Keywords: cancer cell metabolism; cardiac metabolism; clinical trials as topic; heart failure; intermediary metabolism; metabolic targets; systems biology; targeted treatments.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Targeting metabolic enzymes as a strategy in heart failure and cancer. Central metabolic pathways and the involvement of key metabolic enzymes in the synthesis of macromolecules are depicted (shown in gray boxes). α-KG, α-ketoglutarate; G6P, glucose-6-phosphate; GLS, glutaminase; GLUT1, glucose transporter type 1; Glut, glutamate; Gln, glutamine; HK-II, hexokinase II; I, complex I; III, complex III; IV, complex IV; MCT, monocarboxylate transporter; OAA, oxaloacetate; PC, pyruvate dehydrogenase complex; PDK, pyruvate dehydrogenase kinase; Succ, succinate V, complex V.

Similar articles

Cited by

References

    1. Lehninger AL, Nelson DL, Cox MM. Lehninger Principles of Biochemistry. New York, NY: Freeman WH; (2013).
    1. Sheng S, Chen D, Van Eyk JE. Multidimensional liquid chromatography separation of intact proteins by chromatographic focusing and reversed phase of the human serum proteome: optimization and protein database. Mol Cell Proteomics (2006) 5:26–34. 10.1074/mcp.T500019-MCP200 - DOI - PubMed
    1. Agnetti G, Kaludercic N, Kane LA, Elliott ST, Guo Y, Chakir K, et al. . Modulation of mitochondrial proteome and improved mitochondrial function by biventricular pacing of dyssynchronous failing hearts. Circ Cardiovasc Genet. (2010) 3:78–87. 10.1161/CIRCGENETICS.109.871236 - DOI - PMC - PubMed
    1. Chouchani ET, Pell VR, Gaude E, Aksentijevic D, Sundier SY, Robb EL, Murphy MP, et al. . Ischaemic accumulation of succinate controls reperfusion injury through mitochondrial ROS. Nature (2014) 515:431–5. 10.1038/nature13909 - DOI - PMC - PubMed
    1. Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, et al. . Proteomics. Tissue-based map of the human proteome. Science (2015) 347:1260419. 10.1126/science.1260419 - DOI - PubMed

LinkOut - more resources